scispace - formally typeset
M

Michela Roberto

Researcher at Sapienza University of Rome

Publications -  82
Citations -  901

Michela Roberto is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 13, co-authored 64 publications receiving 525 citations.

Papers
More filters
Journal ArticleDOI

The sexist behaviour of immune checkpoint inhibitors in cancer therapy

TL;DR: Different mechanisms could be involved in sex differences with regard to immunotherapy and these differences could be relevant to identify immunological targets in order to draw studies exploring novel combinations of immunotherapy agents.
Journal ArticleDOI

Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents.

TL;DR: In this article, the main studies about clinical effects of several target inhibitors are reviewed, describing properly the most prominent mechanisms of both intrinsic and acquired resistance.
Journal ArticleDOI

A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab.

TL;DR: A nomogram based on easily available and inexpensive clinical factors showing a good performance in predicting individual OS probability among NSCLC patients treated with nivolumab is developed and could be valuable to clinicians in more accurately driving treatment decision in daily practice as well as enrollment onto clinical trials.
Journal ArticleDOI

Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines

TL;DR: Lean body mass loss is associated with higher grade of toxicity in early breast cancer patients receiving adjuvant chemotherapy and L3 skeletal muscle index is an independent predictor of severe toxicity in multivariate analysis.
Journal ArticleDOI

Circulating tumor cells count predicts survival in colorectal cancer patients.

TL;DR: It is found that the presence of CTCs is associated with a reduced survival in colorectal cancer patients and further studies aimed at testing such a predictive value in early stage coloreCTal cancer are awaited.